Retina Today

Featured

Ophthalmic Oncology Perspectives at ARDS

During the 54th annual meeting, Tara A. McCannel, MD, PhD, explored the utility of prognostic biopsy and the psychological ups and downs that come with a cancer diagnosis.

James Winebrake, MD

Starting Retina Fellowship: Four Strategies for Success

Make the most of this pivotal time in your retina career.

Justin C. Muste, MD, and David Fell, MD

Novel MOAs in Wet AMD

The pipeline is full of therapies that hold promise for extending treatment efficacy.

Lejla Vajzovic, MD, FASRS; Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi

Anti-VEGF Step Therapy: An Update

Despite ongoing advocacy efforts, this payer policy persists, putting vision at risk.

Lucas McGuire, BS; Baseer Ahmad, MD; and Jennifer Adeghate, MD, PhD

Featured Supplements

Business Matters: When and How To Hire

Editorially independent content supported with advertising by EyePoint

Understanding Fast Progression in Geographic Atrophy

Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence

Editorially Independent Content, Supported With Advertising From Astellas

One to Watch: Samir N. Patel, MD

Editorially independent supported by Abbvie and Regenxbio

Rising Stars in Retina: Prashant D. Tailor, MD

Editorially independent supported by Abbvie and Regenxbio

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.

Resources

May/June 2026

May/June 2026 | Meeting Minutes

Angiogenesis 2026: Highlights

New data on wet and dry AMD therapies, AI, and more.

Alex Brodin, MA, Senior Editor, and Rebecca Hepp, MA, Editor-in-Chief

May/June 2026 | Medical Retina

Drug Interactions in Immunosuppressive Therapy for Uveitis

A review of the toxic relationships to avoid when managing patients with uveitis.

Ioannis Papasavvas, MD, and Carl P. Herbort, Jr, MD, PD

May/June 2026 | Up Front

Retina Then and Now: May/June Spotlight

As part of our 20th anniversary, Retina Today is digging into the archives to reflect on how much the profession has changed.

Michael S. Ip, MD

May/June 2026 | Features

Pearls and Pitfalls of Treating GA and Wet AMD

Concurrent therapy can pose clinical challenges. Here’s how you can manage these patients and maximize outcomes.

Sean D. Adrean, MD, FAAO, and Wesley Han, BS

View Entire Issue

Popular Articles

March 2026 Insert | One To Watch

One to Watch: Archana A. Nair, MD, MS

Archana A. Nair, MD, MS

April 2026 Insert

One to Watch: Samir N. Patel, MD

Samir N. Patel, MD

March 2026 Supplement | Digital Supplement

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

November/December 2025 Supplement

Preserving Vision in Macular Telangiectasia Type 2

Jay Chhablani, MD, and Lihteh Wu, MD

April 2026 | Features

Imaging Epiretinal Proliferation Using OCT

En face OCT–based identification of proliferative changes may guide surgical strategies in full-thickness macular holes.

Kotaro Tsuboi, MD

Stay updated on the most important business acumen in a concise and easy-to-digest format.

View Resource

Recent Supplements

Understanding Fast Progression in Geographic Atrophy

View Insert

Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence

Editorially Independent Content, Supported With Advertising From Astellas

View Insert

Business Matters: When and How To Hire

Editorially independent content supported with advertising by EyePoint

View Supplement

One to Watch: Samir N. Patel, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Rising Stars in Retina: Prashant D. Tailor, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.

View Supplement

Featured Authors

Manish Nagpal, MS, FRCS, FASRS

Ahmedabad, India

Racemose Hemangioma An Atlas of Multimodal Imaging in Pediatrics DRIL: A Robust Imaging Biomarker in DME Catching Familial Exudative Vitreoretinopathy Early

Carol L. Shields, MD

Choroidal Nevus Growth Into Melanoma in a Young Patient Reducing Chemotherapy Duration for High-Risk Retinoblastoma Does Iris Color Matter in Uveal Melanoma? Tissue Glue-Assisted Plaque Radiotherapy for Uveal Melanoma

María H. Berrocal, MD

The New Retina OR: The Latest Vitrectomy Tools Retinectomy for TRD/RRD With PDR and Cataract Your Favorite Secondary IOL Technique Tackle Secondary IOLs With Ease

Eyetube Retina Series

EYETUBE RETINA MEETING COVERAGE

Featured

Ophthalmic Oncology Perspectives at ARDS

May/June 2026

Popular Articles

Keep in touch

Retina News

Featured Resource